Search Results

Ranolazine 100mg 100mg  | Purity Not Available

Adooq Bioscience

Ranolazine is a partial fatty acid oxidation inhibitor, shifts ATP production from fatty acid to more oxygen-efficient carbohydrate oxidation.

More Information Supplier Page

Ramelteon 50mg 50mg  | Purity Not Available

Adooq Bioscience

Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.

More Information Supplier Page

Ramelteon 5mg 5mg  | Purity Not Available

Adooq Bioscience

Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.

More Information Supplier Page

Ramelteon 25mg 25mg  | Purity Not Available

Adooq Bioscience

Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.

More Information Supplier Page

Ramelteon (TAK-375) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.

More Information Supplier Page

Ramelteon 10mg 10mg  | Purity Not Available

Adooq Bioscience

Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.

More Information Supplier Page

R935788 50mg 50mg  | Purity Not Available

Adooq Bioscience

R935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.

More Information Supplier Page

R935788 5mg 5mg  | Purity Not Available

Adooq Bioscience

R935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.

More Information Supplier Page